The news that CRISPR-Cas9 gene editing in its current form may not work in a substantial fraction of people due to many of us having immunity to Cas9 came as a shock to many, but if you think about it, maybe it’s not so surprising. I don’t see it as the end of the world. A (preprint) from …
Keep calm & CRISPR on: perspectives on report of human Cas9 immunity Read More »
The FDA started off 2018 with a bang on the direct-to-consumer stem cell clinic front with a warning letter on January 3rd to American CryoStem, a firm involved in processing and distributing adipose stem cells. The company’s ATCELL™ adipose stem cell product was the focus of much of letter. The FDA indicated in the warning …
FDA Issues 1st Stem Cell Warning Letter of 2018 to American CryoStem Read More »
The idea of using stem cells for scleroderma seems a bit more promising today. A new NIH-funded study reported in the New England Journal of Medicine (NEJM) gives some hope for the use of a combination of a specific type of myeloablation and a transplant of hematopoietic stem cells (HSC). This approach yields improved long-term …
Stem cells for scleroderma, new NEJM article reports promise Read More »
Looking for a stem cell journal? If you need to publish your latest exciting stem cell manuscript or are wanting to read some stem cell and regenerative medicine articles, you need a stem cell and regenerative medicine journal list. In 2013, I published a list of this kind, but now that it’s 2018, I figured …